FLIPCritical Analysis of Pharmaceutical Marketing
This is a course designed to acquaint students with critical aspects of drug development, marketing, utilization, and evaluative science. The goal of the course is to improve prescribing practices and the outcomes of drug therapy by: 1) educating health professionals at all levels of training about the drug development and approval process; 2) making health professionals aware of pharmaceutical industry marketing practices and assisting them in developing the knowledge and skills to evaluate those marketing techniques; and 3) providing examples and strategies for evaluating existing sources of drug information, and for accessing unbiased sources of information about drugs.
Course Materials
Course Syllabus
Lesson 1: Introduction/Neurontin Case History
Lesson 2: Role/Value of Drug Formularies
Lesson 3: Examples of Misleading Pharmaceutical Marketing
Lesson 4-5: Review of Statistics and Trial Design
Lesson 6: Surrogate vs. Clinical Endpoints
Lesson 7: Marginal and Comparative Efficacy and Safety Information
Lesson 8: Pharmaceutical Marketing Strategies
Lesson 9: Drug Appropriateness for Specific Indications and Criteria
Lesson 10: Role/Limitations of FDA Regulatory Process
Lesson 11: Safety issues related to limited populations exposed in pre-marketing studies
Lesson 12: Drug Costs Drug Pricing and Pharmacoeconomics
Lesson 13: Alternate Information Sources
Lesson 14: Principles of Rational Prescribing